1Penault-Llorca F,Adelaide J,Houvenaeghel G,et al.Optimization of immunohistochemical detection of ERBB2 in human breast cancer: impact of fixation[].Journal of Paleopathology.1994
2Jacobs TW,Gown AM,Yaziji H,et al.Comparison of fluorescence in situ hybridization and immunohistochemistry for the evaluation of HER-2/neu in breast cancer[].Journal of Clinical Oncology.1999
3Pauletti G,Godolphin W,Press MF,et al.Detection and quantitation of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization[].Oncegene.1996
4Jacobs TW,Gown AM,Yaziji H,et al.Specificity of HercepTest in determining HER-2/neu status of breast cancers using the United States Food and Drug Administration-approved scoring system[].Journal of Clinical Oncology.1999
5Allred DC,Harvey JM,Berardo M,et al.Prognostic and predictive factors in breast cancer by immunohistochemical analysis[].Modern Pathology.1998
6Andrulis DC,Bull SB,Blackstein ME,et al.Neu/erbB-2 amplification idetifies a poor-prognosis group of women with node-negative breast cancer.Toronto Breast Cancer Study Group[].Journal of Clinical Oncology.1998
